Day: September 11, 2020

New post hoc data from Phase III ASCLEPIOS trials showed newly diagnosed, treatment-naïve patients experienced reductions in annualized relapse rates, MRI lesion activity and reductions in time to disability worsening when treated with Kesimpta vs teriflunomide1Additional safety data in over 1,800 patients who continued Kesimpta treatment or switched therapy from previous studies reinforce the favorable safety profile of Kesimpta in patients with relapsing forms of multiple sclerosis (RMS)2 Baseline serum neurofilament light chain (NfL) levels in the ASCLEPIOS trials demonstrated a prognostic value for disease activity and worsening in all patients, including newly diagnosed, treatment-naïve patients3 Kesimpta is the first and only FDA-approved, self-administered, targeted B-cell therapy for adult with RMS4The digital press release with...

SCOTTSDALE, Ariz., Sept. 11, 2020 (GLOBE NEWSWIRE) — Electromedical Technologies, Inc. (OTCMKTS:EMED) (the “Company”), a pioneer in the development and manufacturing of bioelectronic devices, is pleased to announce the hiring of Dr Rakhim Bulibekov  as in-house biophysicist to work directly with Nazarbayev University, Nur-Sultan, Kazakhstan, in the development of a comprehensive research program to study effects of electro-modulation on the insulin-dependent glucose uptake, pro-inflammatory or stress-dependent cytokine secretion, hypertension, tumor growth and viral infection in mammalian animal models. Regulation of the physiological responses by electro-modulation will provide a leverage for corrections of disease related physiological defects.The proposed Phase I studies in the animal models will serve to lay a foundation for...

It is the first time that Hong Kong connects directly with Mexico. The flight traveled more than 14 thousand kilometers with an Aeromexico Boeing 787 Dreamliner aircraft.  Mexico City, Sept. 11, 2020 (GLOBE NEWSWIRE) — Aeromexico registered a new record with the longest-range flight in the history of Mexican aviation. This is the first direct operation of the company between Hong Kong International Airport and Mexico City, with a distance of 14,170 kilometers, 55 more than its recent flight between Shenzhen, China, and the country’s capital.  One of the 19 airline’s Boeing 787 aircraft was used as a private charter operation to transport cargo even in the passenger cabin. This airplane is one of the most modern, efficient, and least polluting in the world. It produces 57% less noise pollution on takeoff and landing, and 20%...

BROOKFIELD, Wis, Sept. 11, 2020 (GLOBE NEWSWIRE) — CIB Marine Bancshares, Inc. (the “Company” or “CIBM”) (OTCQB: CIBH), announced that at 4:59a.m., Central Time, on September 14, 2020 (the “Effective Date”), it will affect a 1-for-15 reverse stock split, as previously approved by its Board of Directors and a majority of its common shareholders.  On the Effective Date, the shares of the Company’s common stock, $1.00 par value per share (the “Common Stock”), will begin trading on a split-adjusted basis. The Company’s trading symbol is expected to change to “CIBHD” on the Effective Date and will remain as such for a period of 20 trading days, after which the Company’s trading symbol will revert back to the original symbol of “CIBH”. The Company’s CUSIP number will change to 12542L400 with respect to all shares of Common Stock traded...

 

DALLAS, Sept. 11, 2020 (GLOBE NEWSWIRE) — In the news release titled, “Dave & Buster’s Reports Second Quarter Financial Results; Provides Update on Status of Store Re-openings and Encouraging Business Recovery Trends” from September 10, 2020 the Company is issuing an updated version to clarify that the second quarter comparable store sales decrease of 87% was for the entire 115 comparable store sales base, 47 of which were closed, and also to update the sales figure for all 115 comparable stores and for the 68 reopened comparable stores during the two-week period ended September 7, 2020. The complete corrected text follows:Dave & Buster’s Entertainment, Inc., (NASDAQ:PLAY), (“Dave & Buster’s” or “the Company”), an owner and operator of entertainment and dining venues,...

OMAHA, Neb., Sept. 11, 2020 (GLOBE NEWSWIRE) — Intrado Corporation (“Intrado” or the “Company”), a global leader in technology-enabled services, announced today that it has acquired substantially all the assets of Syn-Apps LLC, a pioneer in Internet of Things (“IoT”) and mass notification software.Syn-Apps’ Revolution platform unites disparate on- and off-network communication devices into a single, easy-to-use interface to communicate critical information more efficiently, safely, and reliably. Thousands of organizations have integrated Syn-Apps’ solutions with phones, speakers, mobile devices, computers, digital or video signs/boards, panic buttons, fire panels, cameras, and hundreds of other internal systems and services.Intrado is building the world’s only end-to-end intelligent 911 platform for public safety. The Intrado nationwide...

EDEN PRAIRIE, Minn., Sept. 11, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the company will participate in Lake Street Capital Markets’ 4th Annual Best Ideas Growth Conference, being held virtually.  Nestor Jaramillo, President and Chief Operating Officer, and Claudia Drayton, Chief Financial Officer, will be holding one-on-one meetings with investors on Thursday, September 17, 2020.About CHF SolutionsCHF Solutions, Inc. (CHFS) is a medical device company dedicated to changing the lives of patients suffering from fluid overload through science, collaboration, and innovation. The company is focused on developing, manufacturing and commercializing the Aquadex SmartFlow™ system for ultrafiltration therapy. CHF...

EMERYVILLE, Calif., Sept. 11, 2020 (GLOBE NEWSWIRE) — Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, announced today two presentations on GOCOVRI® (amantadine) extended release capsules (ADS-5102) for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy at the Movement Disorder Society (MDS) 2020 Virtual Congress, September 12-16, 2020.“These presentations provide further evidence that GOCOVRI may reduce OFF time for people with Parkinson’s, with prolonged effects for at least two years,” said Jean Hubble MD, Vice President, Medical Affairs at Adamas. “Both dyskinesia and OFF disrupt daily activities for people with PD and treating dyskinesia should...